AUG 13, 2026 · PHASE 1 TRIAL
A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234
ClinicalTrials.gov
Phase 1 bioavailability study in healthy volunteers with surrogate endpoints (plasma concentrations); no results posted in this registry record.
Reported
Planned enrollment19
PhasePHASE 1
Primary outcome 1Cmax (Maximum observed plasma concentration)